ArticleFrontiers in microbiology2026
Optimized MT-Capture targeted enrichment sequencing for the complete genome of norovirus in stool and sewage samples.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human norovirus is a major acute gastroenteritis pathogen with high genotypic diversity, mutation, and recombination rates. Existing sequencing methods for monitoring its genetic variations are limited by low sensitivity and contamination risk. This study optimized our previously established Micro Target Hybrid Capture System (MT-Capture) by increasing nucleic acid input, streamlining library preparation, and introducing a deployable USER enzyme-based contamination prevention system. The optimized protocol completes library preparation and capture within 7 hours. Compared with multiplex PCR sequencing, optimized MT-Capture avoids primer updates, captures multiple genotypes with improved compatibility, and detects low-abundance samples more efficiently. The USER enzyme degrades contaminating amplicons, ensuring data authenticity. The MT-Capture-USER system provides a rapid, sensitive, and contamination-resistant approach for norovirus whole-genome sequencing and epidemiological surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.